Search clinical trials for: Empagliflozin + Potassium Chloride

Total 5466 results

University of Pennsylvania

Recruiting

SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial

Heart Failure With Preserved Ejection Fraction

United States
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Type2 Diabetes

Korea, Republic of
Aga Khan University

Unknown

Comparison of Enteral Versus Intravenous Potassium Supplementation (EIPS)

Acute Hypokalemia

Pakistan
University of Pennsylvania

Completed

Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS) (PULSE-AS)

Aortic Valve Stenosis

United States
Frank Mose
Herning Hospital

Completed

The Effect of Orally Administrated Nitrate on Renal Parameters and Systemic Haemodynamics (APNI)

Hypertension

Denmark
National Institute of Diabetes and Digestive and...

Terminated

Pre-ESRD Syndrome in High Risk African Americans

Blood Pressure

United States
University Medical Center Groningen

Completed

Comparison of Two Potassium Targets Within the Normal Range in Intensive Care Patients (GRIP-COMPASS)

Cardiac Surgery | Critically Ill | Thoracic Surgery

Netherlands
University of Pennsylvania

Completed

Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF

Heart Failure | Diastolic Heart Failure

United States
University of Pennsylvania
Northwestern University

Completed

Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)

Heart Failure

United States
University of Delaware

Recruiting

The Potassium Supplementation Study

Cardiovascular Risk Factor | Cardiovascular Health

United States
Centre Hospitalier Universitaire Vaudois
University College, London; Great Ormond Street Hospital for Children NHS Foundation...

Not yet recruiting

Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale

Heart Failure

Switzerland, United Kingdom
Florida State University

Completed

Dietary Nitrate Supplementation and Crossfit Athletes

Performance

United States
Assiut University

Not yet recruiting

SGLT2 Inhibitors and Perioperative Period

Perioperative Complication
Shanghai First Maternity and Infant Hospital
Children's Hospital of Fudan University; International Peace Maternity and...

Unknown

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

Twin Pregnancy With Antenatal Problem | Chromosome Abnormality
Tulane University
National Institute of General Medical Sciences (NIGMS)

Recruiting

Potassium Intake-response Trial to Control Hypertension (PITCH)

Blood Pressure

United States
National Taiwan University Hospital

Recruiting

SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning

Ventilator Lung | Heart Failure Acute

Taiwan
Sohag University

Not yet recruiting

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Fatty Liver, Nonalcoholic
October 6 University
University of Florida; Beni-Suef University; National Heart Institute, Egypt

Recruiting

Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients

Heart Failure | Genetic Polymorphisms

United States
The George Institute
Victor Chang Cardiac Research Institute; St Vincent's Centre for Applied Medical...

Recruiting

Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial

Heart Failure With Preserved Ejection Fraction

Australia
Boehringer Ingelheim
Eli Lilly and Company

Completed

Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Japan
University of Dundee
British Heart Foundation

Completed

SGLT2 Inhibition in Combination With Diuretics in Heart Failure (RECEDE-CHF)

Heart Failure | Type 2 Diabetes Mellitus

United Kingdom
Baptist Health South Florida

Terminated

The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis (Neut-WKBH)

Hypokalemia

United States
Centro Universitario de Ciencias de la Salud, Mexico

Active, not recruiting

Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes

Diabetes Mellitus Type 2 Without Complication

Mexico
Barts & The London NHS Trust

Completed

The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy (NITRATE-CIN)

Acute Coronary Syndrome | Acute Kidney Injury | Contrast-induced Nephropathy

United Kingdom
Beijing Anzhen Hospital

Recruiting

The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.

Coronary Artery Disease | Diabete Mellitus

China
Sun Yat-sen University

Completed

Instant and Lasting Relief Effects of Strontium Chloride/Potassium Nitrate Dentifrice on Dentin Hypersensitivity

Dentine Hypersensitivity

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and Female

Healthy

Germany
Norgine

Completed

Constipation Associated With Irritable Bowel Syndrome (IBS-C)

Constipation

United Kingdom, Italy, Czech Republic, France, Germany, Poland, Sweden
Clinical Research Centre, Malaysia
University of Malaya; Ministry of Health, Malaysia

Recruiting

The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD) (EpiCAD)

Coronary Artery Disease

Malaysia
Damanhour University

Recruiting

Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients

Heart Failure | Reduced Ejection Fraction Heart Failure

Egypt
Kiyuk Chang
Seoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaborators

Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients With Acute Myocardial Infarction, a Prospective, Multi-center Registry Study (RECORD-AMI)

Myocardial Infarction | Diabetes Mellitus, Type 2

Korea, Republic of
Boehringer Ingelheim
Eli Lilly and Company

Completed

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Hypertension | Diabetes Mellitus, Type 2

United States
University of Turin, Italy

Unknown

Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors (GliRACo1)

Diabetes Mellitus, Type 2 | Body Weight Changes | Arterial Hypertension

Italy
Ain Shams University

Not yet recruiting

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Lupus Nephritis

Egypt
Glostrup University Hospital, Copenhagen
Danish Heart Foundation

Completed

Blood Pressure Regulation - Role of Potassium

Hypertension | Blood Pressure

Denmark
The Queen Elizabeth Hospital

Completed

Safety of Continuous Potassium Chloride Infusion in Critical Care (ASPIC)

Arrhythmias, Cardiac | Hypokalemia

Australia
Imperial College London
Royal Brompton & Harefield NHS Foundation Trust

Not yet recruiting

Therapy to Maintain Remission in Dilated Cardiomyopathy (TRED-HF2)

Heart Diseases | Heart Failure | Cardiomyopathies | Cardiomyopathy, Dilated
Centro Universitario de Ciencias de la Salud, Mexico

Unknown

Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Mexico
University of Texas Southwestern Medical Center

Withdrawn

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Hypertension | Pre-hypertension

United States
Medical University of Warsaw
Medical University of Graz; Medical University of Vienna; Poznan University of... and other collaborators

Recruiting

Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure (EMPATHY)

Acute Decompensated Heart Failure

Poland
Federal University of São Paulo

Completed

Fluid Therapy During Brain Tumor Resection in Children

Brain Neoplasms

Brazil
University of Pisa

Unknown

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections. (UTI-flog)

Type 2 Diabetes | Urinary Tract Infections

Italy
Tufts University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Effect of Potassium Bicarbonate Supplementation on Bone and Muscle in Older Adults

Sarcopenia | Osteoporosis

United States
Boehringer Ingelheim

Completed

Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Texas Tech University
American Society for Nutrition

Not yet recruiting

Increasing Vegetable Intake Using Monosodium Glutamate: A Reduced-Effort Intervention

Sodium Excess | Healthy Nutrition | Culinary Medicine
Aristotle University Of Thessaloniki

Unknown

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics (PREHYPD)

Hypertension | Type II Diabetes

Greece
Morten Schou

Completed

Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction (Empire HF)

Heart Failure With Reduced Ejection Fraction

Denmark
Medical University of Vienna
Attoquant Diagnostics

Completed

EMPRA (EMPagliflozin and RAs in Kidney Disease) (EMPRA)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3

Austria
Boehringer Ingelheim
Eli Lilly and Company

Completed

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets

Healthy

United States
Cairo University
Riyadh Fertility and Reproductive Health center

Completed

Fetal Reduction: Mechanical vs Chemical

Multiple Pregnancy

Egypt

Search clinical trials for: Empagliflozin + Potassium Chloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations